v3.26.1
CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance, Shares at Dec. 31, 2024     2,417,435      
Beginning Balance, Shares at Dec. 31, 2024   4,915,299        
Beginning Balance, Amount at Dec. 31, 2024 $ (125,859)   $ 14 $ 9,954 $ 72 $ (135,899)
Beginning Balance, Amount at Dec. 31, 2024   $ 120,356        
Stock-based compensation expense 671     671    
Net Income (Loss) (3,425)         (3,425)
Net unrealized loss on available-for-sale investments (57)       (57)  
Ending Balance, Shares at Mar. 31, 2025     2,417,435      
Ending Balance, Shares at Mar. 31, 2025   4,915,299        
Ending Balance, Amount at Mar. 31, 2025 (128,670)   $ 14 10,625 15 (139,324)
Ending Balance, Amount at Mar. 31, 2025   $ 120,356        
Beginning Balance, Shares at Dec. 31, 2024     2,417,435      
Beginning Balance, Shares at Dec. 31, 2024   4,915,299        
Beginning Balance, Amount at Dec. 31, 2024 (125,859)   $ 14 9,954 72 (135,899)
Beginning Balance, Amount at Dec. 31, 2024   $ 120,356        
Net Income (Loss) (13,328)          
Net unrealized loss on available-for-sale investments (93)          
Ending Balance, Shares at Jun. 30, 2025     2,430,956      
Ending Balance, Shares at Jun. 30, 2025   4,915,299        
Ending Balance, Amount at Jun. 30, 2025 (137,882)   $ 14 11,352 (21) (149,227)
Ending Balance, Amount at Jun. 30, 2025   $ 120,356        
Beginning Balance, Shares at Mar. 31, 2025     2,417,435      
Beginning Balance, Shares at Mar. 31, 2025   4,915,299        
Beginning Balance, Amount at Mar. 31, 2025 (128,670)   $ 14 10,625 15 (139,324)
Beginning Balance, Amount at Mar. 31, 2025   $ 120,356        
Issuance of common stock upon exercise of stock options, Shares     13,521      
Issuance of common stock upon exercise of stock options, Amount 51     51    
Stock-based compensation expense 676     676    
Net Income (Loss) (9,903)         (9,903)
Net unrealized loss on available-for-sale investments (36)       (36)  
Ending Balance, Shares at Jun. 30, 2025     2,430,956      
Ending Balance, Shares at Jun. 30, 2025   4,915,299        
Ending Balance, Amount at Jun. 30, 2025 (137,882)   $ 14 11,352 (21) (149,227)
Ending Balance, Amount at Jun. 30, 2025   $ 120,356        
Beginning Balance, Shares at Dec. 31, 2025     2,451,167      
Beginning Balance, Shares at Dec. 31, 2025   4,915,299        
Beginning Balance, Amount at Dec. 31, 2025 (143,419)   $ 14 14,239 35 (157,707)
Beginning Balance, Amount at Dec. 31, 2025 120,356 $ 120,356        
Issuance of common stock upon exercise of stock options, Shares     17,026      
Issuance of common stock upon exercise of stock options, Amount 93     93    
Stock-based compensation expense 1,970     1,970    
Net Income (Loss) (17,347)         (17,347)
Net unrealized loss on available-for-sale investments (35)       (35)  
Ending Balance, Shares at Mar. 31, 2026     2,468,193      
Ending Balance, Shares at Mar. 31, 2026   4,915,299        
Ending Balance, Amount at Mar. 31, 2026 (158,738)   $ 14 16,302 0 (175,054)
Ending Balance, Amount at Mar. 31, 2026   $ 120,356        
Beginning Balance, Shares at Dec. 31, 2025     2,451,167      
Beginning Balance, Shares at Dec. 31, 2025   4,915,299        
Beginning Balance, Amount at Dec. 31, 2025 (143,419)   $ 14 14,239 35 (157,707)
Beginning Balance, Amount at Dec. 31, 2025 120,356 $ 120,356        
Net Income (Loss) (23,824)          
Net unrealized loss on available-for-sale investments (37)          
Ending Balance, Shares at Jun. 30, 2026     2,485,234      
Ending Balance, Shares at Jun. 30, 2026   4,915,299        
Ending Balance, Amount at Jun. 30, 2026 (164,846)   $ 14 16,673 (2) (181,531)
Ending Balance, Amount at Jun. 30, 2026 120,356 $ 120,356        
Beginning Balance, Shares at Mar. 31, 2026     2,468,193      
Beginning Balance, Shares at Mar. 31, 2026   4,915,299        
Beginning Balance, Amount at Mar. 31, 2026 (158,738)   $ 14 16,302 0 (175,054)
Beginning Balance, Amount at Mar. 31, 2026   $ 120,356        
Issuance of common stock upon exercise of stock options, Shares     17,041      
Issuance of common stock upon exercise of stock options, Amount 144     144    
Stock-based compensation expense 227     227    
Net Income (Loss) (6,477)         (6,477)
Net unrealized loss on available-for-sale investments (2)       (2)  
Ending Balance, Shares at Jun. 30, 2026     2,485,234      
Ending Balance, Shares at Jun. 30, 2026   4,915,299        
Ending Balance, Amount at Jun. 30, 2026 (164,846)   $ 14 $ 16,673 $ (2) $ (181,531)
Ending Balance, Amount at Jun. 30, 2026 $ 120,356 $ 120,356